Vaxxinity, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of revenue
Gross (loss) profit
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other (income) expense:
Interest and other expense
Interest and other income
Change in fair value of convertible notes
Change in fair value of simple agreement for future equity
Change in fair value of warrant liability
(Gain) loss on foreign currency translation, net
Other (income) expense
Other (income)
Loss before income taxes
Provision for income taxes
Net loss
Net loss per share, basic and diluted
Weighted average common shares outstanding, basic and diluted
Net loss per share, basic
Net loss per share, diluted
Weighted average common shares outstanding, basic
Weighted average common shares outstanding, diluted
Other comprehensive loss:
Unrealized loss (gain) on investments
Other comprehensive loss (income)
Comprehensive loss

Comments